Epilepsy and orphan drug development: an interview with Ana Mingorance

Written by Ana Mingorance (Loulou Foundation, London, UK)

In this Expert Perspective from the Video Journal of Biomedicine, Ana Mingorance (Loulou Foundation, London, UK) speaks about the current status of drug development for epilepsy. Ana also describes how the landscape of this field has changed, with new developments in technology as well as challenges associated with the regulatory approval of new drugs leading to a shift in focus to developing novel drugs to treat orphan epilepsy indications.  About Ana Mingorance:  Ana Mingorance is a neuroscientist specialized in drug discovery for rare epilepsy syndromes. She is the Chief Development Officer of the Loulou Foundation and an independent consultant helping...

To view this content, please register now for access

It's completely free